Astrana Health (ASTH) CAO surrenders 662 shares for tax withholding

Rhea-AI Filing Summary

Astrana Health, Inc. Chief Accounting Officer Glenn Sobotka reported a routine tax-withholding transaction involving company stock. On March 26, 2026, he surrendered 662 shares of common stock at $24.27 per share to cover taxes on restricted stock that vested that day. Following this non‑market disposition, he directly holds 14,039 shares, including unvested restricted stock awards. These include 4,824 shares scheduled to vest in three equal annual installments beginning on March 26, 2027, and 8,269 shares that will vest only if certain performance goals are achieved.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sobotka Glenn

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	662	$24.27	$16K

Holdings After Transaction: Common Stock — 14,039 shares (Direct)

Footnotes (1)

1. Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on March 26, 2026. Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 4,824 shares, which will vest in three equal annual installments beginning on March 26, 2027; and (ii) 8,269 shares, which will vest subject to the achievement of certain performance goals.

Key Figures

Shares surrendered for tax withholding: 662 shares Implied share value: $24.27 per share Shares held after transaction: 14,039 shares +2 more

5 metrics

Shares surrendered for tax withholding 662 shares Common stock surrendered on March 26, 2026

Implied share value $24.27 per share Value used for tax-withholding disposition

Shares held after transaction 14,039 shares Direct common stock holdings following disposition

Time-based restricted stock 4,824 shares Vest in three equal annual installments from March 26, 2027

Performance-based restricted stock 8,269 shares Vest upon achievement of performance goals

Key Terms

restricted stock, tax withholding obligations, performance goals, vesting, +1 more

5 terms

restricted stock financial

"Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

tax withholding obligations financial

"Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock"

performance goals financial

"8,269 shares, which will vest subject to the achievement of certain performance goals"

Performance goals are specific, measurable targets a company sets for financial results, operational milestones, or individual roles—examples include revenue, profit, production levels, or completion of a project. They matter to investors because meeting or missing these targets influences management pay, future forecasts, deal-related payments and market confidence; think of them as a scoreboard that helps outsiders judge whether the business is performing as promised.

vesting financial

"restricted stock, which will vest as follows (in each case subject to continuous employment"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

tax-withholding disposition financial

"transaction_action: "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sobotka Glenn

(Last) (First) (Middle)

C/O ASTRANA HEALTH, INC.

1668 S. GARFIELD AVENUE, 2ND FLOOR

(Street)

ALHAMBRA CALIFORNIA 91801

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/26/2026		F		662(1)	D	$24.27	14,039(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on March 26, 2026.

2. Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 4,824 shares, which will vest in three equal annual installments beginning on March 26, 2027; and (ii) 8,269 shares, which will vest subject to the achievement of certain performance goals.

	/s/ Kathy Diep, as Attorney-in-Fact	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Astrana Health (ASTH) report for Glenn Sobotka?

Astrana Health reported that Chief Accounting Officer Glenn Sobotka surrendered 662 shares of common stock to cover tax withholding obligations on vested restricted stock. This was a non-market, tax-related disposition rather than an open-market sale or purchase of shares.

How many Astrana Health (ASTH) shares did the CAO surrender and at what price?

Glenn Sobotka surrendered 662 shares of Astrana Health common stock at a value of $24.27 per share. The shares were used to satisfy tax withholding obligations tied to restricted stock that vested on March 26, 2026, rather than being sold on the open market.

How many Astrana Health (ASTH) shares does Glenn Sobotka hold after this Form 4?

After the reported tax-withholding disposition, Glenn Sobotka directly holds 14,039 shares of Astrana Health common stock. This figure includes unvested restricted stock awards that are scheduled to vest over time or upon achievement of specified performance goals, as described in the filing footnotes.

Is the Astrana Health (ASTH) CAO transaction an open-market sale?

No. The transaction is classified as a tax-withholding disposition, not an open-market sale. Shares were surrendered back to offset tax obligations arising from restricted stock that vested on March 26, 2026, which is a common administrative mechanism in equity compensation plans.

What future vesting conditions apply to Glenn Sobotka’s Astrana Health (ASTH) restricted stock?

His holdings include 4,824 restricted shares that vest in three equal annual installments starting March 26, 2027, contingent on continued employment, and 8,269 restricted shares that will vest only if certain performance goals are met, aligning compensation with company and individual results.